Abstract
Purpose
The purpose of this study is to examine the efficiency of sonoporation with minicircle DNA for the skin wound healing in diabetic mice.
Methods
Minicircle DNA containing the human VEGF165 was constructed and tested in vitro. Diabetes was induced in 2-week old male C57BL/6J mice via streptozotocin (STZ) injection. 6 mm circular skin wounds were made on the mice back. After the subcutaneous injection of the minicircle DNA at the edge of the wound, the mice were exposed to the ultrasound irradiation for the sonoporation. Wound areas were analyzed until the day 12. Blood perfusion and angiogenesis were evaluated using a laser Doppler imaging and CD31 immunostaining, respectively. Re-epithelialization was assessed by histochemical analysis using hematoxylin and eosin staining.
Results
Accelerated wound closure was observed in the mice receiving sonoporation of minicircle-VEGF165, which corresponds to the markedly increased skin blood perfusion and CD31 expression. Histological analysis revealed that the minicircle treated wound tissues showed fully restored normal architectures as compared with the non-treated diabetic controls with the markedly edematous and chaotic morphologies.
Conclusions
Ultrasound mediated gene therapy with the minicircle-VEGF165 is effective for the healing of the skin wound of the diabetic mice.
Similar content being viewed by others
References
P. Martin. Wound healing—aiming for perfect skin regeneration. Science. 276:75–81 (1997) doi:10.1126/science.276.5309.75.
A. J. Singer, and R. A. Clark. Cutaneous wound healing. N. Engl. J. Med. 341:738–746 (1999) doi:10.1056/NEJM199909023411006.
S. Enoch, and D.J. Leaper. Basic science of wound healing. Surgery(Oxford). 26:31–37 (2008) doi:10.1016/j.mpsur.2007.11.005.
M. A. Loot, S. B. Kenter, F. L. Au, W. J. van Galen, E. Middelkoop, J. D. Bos, and J. R. Mekkes. Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls. Eur. J. Cell Biol. 81:153–160 (2002) doi:10.1078/0171-9335-00228.
M. A. Loots, E. N. Lamme, J. Zeegelaar, J. R. Mekkes, J. D. Bos, and E. Middelkoop. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J. Invest. Dermatol. 111:850–857 (1998) doi:10.1046/j.1523-1747.1998.00381.x.
W. J. Jeffcoate, and K. G. Harding. Diabetic foot ulcers. Lancet. 361:1545–1551 (2003) doi:10.1016/S0140-6736(03)13169-8.
T. Dinh, and A. Veves. Microcirculation of the diabetic foot. Curr. Pharm. Des. 11:2301–9 (2005) doi:10.2174/1381612054367328.
Y. Tsurumi, S. Takeshita, D. Chen, M. Kearney, S. T. Rossow, J. Passeri, J. R. Horowitz, J. F. Symes, and J. M. Isner. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation. 94:3281–3290 (1996).
J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:27–31 (1995) doi:10.1038/nm0195-27.
V. Falanga. The chronic wound: impaired healing and solutions in the context of wound bed preparation. Blood Cells Mol. Diseases. 32:88–94 (2004) doi:10.1016/j.bcmd.2003.09.020.
J. Plouet, J. Schilling, and D. Gospodarowicz. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J. 8:3801–3806 (1989).
N. Ferrara, and W. J. Henzel. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161:851–858 (1989) doi:10.1016/0006-291X(89)92678-8.
T. Alon, I. Hemo, A. Itin, J. Pe’er, J. Stone, and E. Keshet. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1:1024–1028 (1995) doi:10.1038/nm1095-1024.
F. Yuan, Y. Chen, M. Dellian, N. Safabakhsh, N. Ferrara, and R. K. Jain. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl. Acad. Sci. U. S. A. 93:14765–14770 (1996) doi:10.1073/pnas.93.25.14765.
K. A. Houck, N. Ferrara, J. Winer, G. Cachianes, B. Li, and D. W. Leung. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5:1806–1814 (1991).
B. Deodato, N. Arsic, L. Zentilin, M. Galeano, D. Santoro, V. Torre, D. Altavilla, D. Valdembri, F. Bussolino, F. Squadrito, and M. Giacca. Recombinant AAV vector encoding human VEGF165 enhances wound healing. Gene Ther. 9:777–785 (2002) doi:10.1038/sj.gt.3301697.
H. J. Kim, J. F. Greenleaf, R. R. Kinnick, J. T. Bronk, and M. E. Bolander. Ultrasound-mediated transfection of mammalian cells. Hum. Gene Ther. 7:1339–1346 (1996) doi:10.1089/hum.1996.7.11-1339.
D. B. Tata, F. Dunn, and D. J. Tindall. Selective clinical ultrasound signals mediate differential gene transfer and expression in two human prostate cancer cell lines: LnCap and PC-3. Biochem. Biophys. Res. Commun. 234:64–67 (1997) doi:10.1006/bbrc.1997.6578.
S. Bao, B. D. Thrall, and D. L. Miller. Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med. Biol. 23:953–959 (1997) doi:10.1016/S0301-5629(97)00025-2.
P. A. Grayburn. Current and future contrast agents. Echocardiography. 19:259–265 (2002) doi:10.1046/j.1540-8175.2002.00259.x.
M. W. Miller. Gene transfection and drug delivery. Ultrasound Med. Biol. 26(Suppl 1):S59–S62 (2000) doi:10.1016/S0301-5629(00)00166-6.
A. M. Darquet, B. Cameron, P. Wils, D. Scherman, and J. Crouzet. A new DNA vehicle for nonviral gene delivery: supercoiled minicircle. Gene Ther. 4:1341–1349 (1997) doi:10.1038/sj.gt.3300540.
A. M. Darquet, R. Rangara, P. Kreiss, B. Schwartz, S. Naimi, P. Delaere, J. Crouzet, and D. Scherman. Minicircle: an improved DNA molecule for in vitro and in vivo gene transfer. Gene Ther. 6:209–218 (1999) doi:10.1038/sj.gt.3300816.
Z. Y. Chen, C. Y. He, A. Ehrhardt, and M. A. Kay. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol. Ther. 8:495–500 (2003) doi:10.1016/S1525-0016(03)00168-0.
K. Ramabadran, M. Bansinath, H. Turndorf, and M. M. Puig. The hyperalgesic effect of naloxone is attenuated in streptozotocin-diabetic mice. Psychopharmacology (Berl). 97:169–174 (1989) doi:10.1007/BF00442244.
M. Anjaneyulu, and P. Ramarao. Studies on gastrointestinal tract functional changes in diabetic animals. Methods Find. Exp. Clin. Pharmacol. 24:71–75 (2002) doi:10.1358/mf.2002.24.2.677129.
E. L. Weber, and P. M. Cannon. Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potential. Hum. Gene Ther. 18:849–860 (2007) doi:10.1089/hum.2007.067.
H. Hee. Ahn, M. S. Lee, M. H. Cho, Y. N. Shin, J. H. Lee, K. S. Kim, M. S. Kim, G. Khang, K. C. Hwang, I. W. Lee, S. L. Diamonde, and H. B. Lee. DNA/PEI nano-particles for gene delivery of rat bone marrow stem cells. Colloids Surf. A, Physicochem. Eng. Asp. 328:1–7 (2008) doi:10.1016/j.colsurfa.2008.06.011.
H. Lv, S. Zhang, B. Wang, S. Cui, and J. Yan. Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release. 114:100–9 (2006) doi:10.1016/j.jconrel.2006.04.014.
S. Mehier-Humbert, and R. H. Guy. Physical methods for gene transfer: improving the kinetics of gene delivery into cells. Adv. Drug Deliv. Rev. 57:733–53 (2005) doi:10.1016/j.addr.2004.12.007.
E. Seifter, G. Rettura, J. Padawer, F. Stratford, D. Kambosos, and S. M. Levenson. Impaired wound healing in streptozotocin diabetes. Prevention by supplemental vitamin A. Ann. Surg. 194:42–50 (1981) doi:10.1097/00000658-198107000-00008.
R. Tsuboi, C. M. Shi, D. B. Rifkin, and H. Ogawa. A wound healing model using healing-impaired diabetic mice. J. Dermatol. 19(11):673–675 (1992).
W. J. Schnedl, S. Ferber, J. H. Johnson, and C. B. Newgard. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes. 43:1326–1333 (1994) doi:10.2337/diabetes.43.11.1326.
G. Lauer, S. Sollberg, M. Cole, I. Flamme, J. Sturzebecher, K. Mann, T. Krieg, and S. A. Eming. Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J. Invest. Dermatol. 115:12–18 (2000) doi:10.1046/j.1523-1747.2000.00036.x.
B. A. Mast, and G. S. Schultz. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen. 4:411–420 (1996) doi:10.1046/j.1524-475X.1996.40404.x.
Y. Taniyama, K. Tachibana, K. Hiraoka, M. Aoki, S. Yamamoto, K. Matsumoto, T. Nakamura, T. Ogihara, Y. Kaneda, and R. Morishita. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther. 9:372–80 (2002) doi:10.1038/sj.gt.3301678.
Q. L. Lu, H. D. Liang, T. Partridge, and M. J. Blomley. Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage. Gene Ther. 10:396–405 (2003) doi:10.1038/sj.gt.3301913.
Y. Taniyama, K. Tachibana, K. Hiraoka, T. Namba, K. Yamasaki, N. Hashiya, M. Aoki, T. Ogihara, K. Yasufumi, and R. Morishita. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation. 105:1233–1239 (2002) doi:10.1161/hc1002.105228.
P. E. Huber, M. J. Mann, L. G. Melo, A. Ehsan, D. Kong, L. Zhang, M. Rezvani, P. Peschke, F. Jolesz, V. J. Dzau, and K. Hynynen. Focused ultrasound (HIFU) induces localized enhancement of reporter gene expression in rabbit carotid artery. Gene Ther. 10:1600–1607 (2003) doi:10.1038/sj.gt.3302045.
S. Mayer, and P. A. Grayburn. Myocardial contrast agents: recent advances and future directions. Prog. Cardiovasc. Dis. 44:33–44 (2001) doi:10.1053/pcad.2001.26438.
Acknowledgements
The part of this work was accepted as an abstract at the 42nd Annual Meeting of the European Association for the Study of Diabetes in Denmark Copenhagen-Malmoe, September 2006. The present study was financially supported by the Inje University Research Grant 2005. We thank Dr. Mark A Kay (Stanford University) for generously providing plasmid p2øC31.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yoon, C.S., Jung, H.S., Kwon, M.J. et al. Sonoporation of the Minicircle-VEGF165 for Wound Healing of Diabetic Mice. Pharm Res 26, 794–801 (2009). https://doi.org/10.1007/s11095-008-9778-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-008-9778-x